Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease

NCT04157933 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

UNKNOWN

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: 009-A1
DRUG: 009-A2
DRUG: 009-A3
DRUG: 009-A0
DRUG: 009-B1 (active --> placebo) crossover
DRUG: 009-B2 (placebo --> active) crossover

Sponsor

Alexza Pharmaceuticals, Inc.